Recognizing and avoiding ototoxicity.
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D000981:Antiprotozoal Agents / Q000009:adverse effects; D001299:Audiometry; D003051:Cochlea / Q000187:drug effects*; D003276:Contraceptives, Oral / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D004357:Drug Synergism; D064420:Drug-Related Side Effects and Adverse Reactions; D004427:Ear Diseases / Q000139:chemically induced*; D005260:Female; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D012459:Salicylates / Q000009:adverse effects; D013792:Thalidomide / Q000009:adverse effects; D014724:Vestibular Function Tests; D014722:Vestibule, Labyrinth / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D000981:Antiprotozoal Agents; D003276:Contraceptives, Oral; D004232:Diuretics; D012459:Salicylates; D013792:Thalidomide